These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 12427014)
1. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide. Cottingham MG; Hollinshead MS; Vaux DJ Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014 [TBL] [Abstract][Full Text] [Related]
2. The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomers. Cottingham MG; Voskuil JL; Vaux DJ Biochemistry; 2003 Sep; 42(36):10863-73. PubMed ID: 12962511 [TBL] [Abstract][Full Text] [Related]
3. Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the AChE concentration present in the complexes. Muñoz FJ; Inestrosa NC FEBS Lett; 1999 May; 450(3):205-9. PubMed ID: 10359075 [TBL] [Abstract][Full Text] [Related]
4. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Castano EM; Prelli F; Wisniewski T; Golabek A; Kumar RA; Soto C; Frangione B Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):599-604. PubMed ID: 7534068 [TBL] [Abstract][Full Text] [Related]
5. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments. Kaneko I; Morimoto K; Kubo T Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586 [TBL] [Abstract][Full Text] [Related]
6. Alzheimer's beta-amyloid: insights into fibril formation and structure from Congo red binding. Inouye H; Kirschner DA Subcell Biochem; 2005; 38():203-24. PubMed ID: 15709480 [TBL] [Abstract][Full Text] [Related]
7. Jean L; Brimijoin S; Vaux DJ J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102 [TBL] [Abstract][Full Text] [Related]
8. A molecular model of Alzheimer amyloid beta-peptide fibril formation. Tjernberg LO; Callaway DJ; Tjernberg A; Hahne S; Lilliehöök C; Terenius L; Thyberg J; Nordstedt C J Biol Chem; 1999 Apr; 274(18):12619-25. PubMed ID: 10212241 [TBL] [Abstract][Full Text] [Related]
9. A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation. De Ferrari GV; Canales MA; Shin I; Weiner LM; Silman I; Inestrosa NC Biochemistry; 2001 Sep; 40(35):10447-57. PubMed ID: 11523986 [TBL] [Abstract][Full Text] [Related]
10. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407 [TBL] [Abstract][Full Text] [Related]
11. Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. Alvarez A; Alarcón R; Opazo C; Campos EO; Muñoz FJ; Calderón FH; Dajas F; Gentry MK; Doctor BP; De Mello FG; Inestrosa NC J Neurosci; 1998 May; 18(9):3213-23. PubMed ID: 9547230 [TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides. Alvarez A; Bronfman F; Pérez CA; Vicente M; Garrido J; Inestrosa NC Neurosci Lett; 1995 Dec; 201(1):49-52. PubMed ID: 8830310 [TBL] [Abstract][Full Text] [Related]
13. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity. Singh PK; Maji SK Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076 [TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. Alvarez A; Opazo C; Alarcón R; Garrido J; Inestrosa NC J Mol Biol; 1997 Sep; 272(3):348-61. PubMed ID: 9325095 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation. Hughes E; Burke RM; Doig AJ J Biol Chem; 2000 Aug; 275(33):25109-15. PubMed ID: 10825171 [TBL] [Abstract][Full Text] [Related]
16. The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation. Castillo GM; Lukito W; Wight TN; Snow AD J Neurochem; 1999 Apr; 72(4):1681-7. PubMed ID: 10098877 [TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase-amyloid-beta-peptide interaction: effect of Congo Red and the role of the Wnt pathway. Inestrosa NC; Alvarez A; Dinamarca MC; Pérez-Acle T; Colombres M Curr Alzheimer Res; 2005 Jul; 2(3):301-6. PubMed ID: 15974895 [TBL] [Abstract][Full Text] [Related]
18. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease. Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279 [TBL] [Abstract][Full Text] [Related]
19. Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro. McParland VJ; Kad NM; Kalverda AP; Brown A; Kirwin-Jones P; Hunter MG; Sunde M; Radford SE Biochemistry; 2000 Aug; 39(30):8735-46. PubMed ID: 10913285 [TBL] [Abstract][Full Text] [Related]